FDA awards GSA breakthrough status for relapsed osteosarcoma treatment
GSK has gained US Food and Drug Administration (FDA) breakthrough therapy designation (BTD) for its B7-H3-targeted ...
Artemis47m
Hard market structural changes likely to endure in reinsurance: Howden
Even while pricing across the reinsurance market has begun to decline from its historically high levels, broking group Howden ...